Calcium is an essential mineral for human health, playing a crucial role in various physiological processes. However, its most notable function is in bone metabolism, where it aids in the construction and maintenance of skeletal tissue. This review aims to shed light on this vital role, providing a comprehensive understanding for healthcare professionals.
Calcium is the principal component of hydroxyapatite, the mineral complex that gives bones their rigidity. During bone formation, osteoblasts secrete a collagen matrix, on which calcium and phosphate ions precipitate to form hydroxyapatite. This process, known as mineralization, is critical for the development of a strong and healthy skeleton.
Bone remodeling is a continuous process where old bone is resorbed by osteoclasts and new bone is formed by osteoblasts. Calcium plays a pivotal role in this process. When blood calcium levels drop, parathyroid hormone (PTH) stimulates osteoclast activity, leading to bone resorption and the release of calcium into the bloodstream. This mechanism ensures calcium homeostasis, highlighting the delicate balance between bone health and overall calcium metabolism.
Given the vital role of calcium in bone metabolism, supplementation is often recommended for individuals at risk of osteoporosis. However, the efficacy of calcium supplements in fracture prevention is a topic of ongoing debate. While some studies suggest a protective effect, others argue the benefits are minimal and may be outweighed by potential cardiovascular risks. Therefore, further research is needed to clarify these conflicting findings.
In conclusion, calcium plays an indispensable role in bone metabolism, contributing to both bone formation and remodeling. Understanding this role is crucial for healthcare professionals, as it can guide strategies for promoting bone health and preventing skeletal disorders. However, the use of calcium supplements requires careful consideration, underscoring the need for continued research in this area.
1.
Prostate cancer detection with PET CT and PET MRI is comparable.
2.
Refractory Multiple Myeloma Responsive to Immunotherapy Plus Low-Dose Radiotherapy
3.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
4.
In NSCLC, subcutaneous Lazertinib + Amivantamab Dosing Is Not Worse Than IV Dosing.
5.
Loncastuximab-Rituximab Boosts Response Rates in R/R Follicular Lymphoma
1.
Innovative Intraoperative Therapies in Neurosurgical Oncology: Advancing Precision and Outcomes
2.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
3.
Holistic Oncology: Advancing Survivorship, Nursing, and Innovative Cancer Care Models
4.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
5.
The Dangers of Supratherapeutic INR: The Need for Increased Awareness and Monitoring
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Thromboprophylaxis In Medical Settings
2.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
4.
Efficient Management of First line ALK-rearranged NSCLC
5.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation